BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
US Market
Holding BIOA?
Track your performance easily

BioAge Labs, Inc. (BIOA) Financial Statements

38 Followers

BioAge Labs, Inc. Financial Overview

BioAge Labs, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; BioAge Labs, Inc. is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Dec 22
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -13.14M$ -11.78M--
EBITDA$ -13.09M$ -11.74M--
Net Income Common Stockholders$ -13.58M$ -12.99M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 159.09M$ 173.99M$ 21.64M$ 27.64M
Total Assets$ 164.40M$ 179.60M$ 25.92M$ 28.43M
Total Debt$ 11.67M$ 13.09M$ 53.25M$ 2.47M
Net Debt$ -147.42M$ -160.90M$ 31.61M$ -25.18M
Total Liabilities$ 18.70M$ 22.28M$ 66.60M$ 8.27M
Stockholders Equity$ 145.70M$ 157.32M$ -40.67M$ 20.16M
Cash Flow-
Free Cash Flow$ -15.82M$ -15.67M--
Operating Cash Flow$ -15.78M$ -15.67M--
Investing Cash Flow$ -35.00K---
Financing Cash Flow$ -2.39M$ 168.00M--
Currency in USD

BioAge Labs, Inc. Earnings and Revenue History

BioAge Labs, Inc. Debt to Assets

BioAge Labs, Inc. Cash Flow

BioAge Labs, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis